تداخلهای دارویی
Bismuth subsalicylate + Dichlorphenamide
شدت: شدید
Bismuth subsalicylate and Dichlorphenamide: major interaction.
آخرین بهروزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصهای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمیشود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Bismuth subsalicylate is hydrolysed to salicylate, and dichlorphenamide is a carbonic anhydrase inhibitor; with salicylates it can accumulate salicylate and worsen metabolic acidosis. Tachypnoea, lethargy and coma have been reported with high-dose aspirin.
معنای این تداخل به زبان ساده
Bismuth subsalicylate and Dichlorphenamide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Bismuth subsalicylate belongs to Gastrointestinal Tract; Dichlorphenamide belongs to Miscellaneous.
چرا رخ میدهد
Carbonic anhydrase inhibition causes metabolic acidosis and reduced salicylate renal clearance, raising salicylate levels
اقدام لازم
Avoid bismuth subsalicylate during dichlorphenamide therapy; if salicylate is needed use lowest dose and monitor acid-base status and symptoms of salicylism.
از داروساز چه بپرسید
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیههای کامل مدیریت Bismuth subsalicylate و Dichlorphenamide، یادداشتهای تکمیلی، جزئیات شواهد و بررسیکننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Bismuth subsalicylate
تداخلات دیگر Dichlorphenamide
پرسشهای متداول
Can I take Bismuth subsalicylate with Dichlorphenamide?
MediHelp rates the interaction as major. Bismuth subsalicylate and Dichlorphenamide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Bismuth subsalicylate is hydrolysed to salicylate, and dichlorphenamide is a carbonic anhydrase inhibitor; with salicylates it can accumulate salicylate and worsen metabolic acidosis. Tachypnoea, lethargy and coma have been reported with high-dose aspirin.
How serious is the interaction between Bismuth subsalicylate and Dichlorphenamide?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid bismuth subsalicylate during dichlorphenamide therapy; if salicylate is needed use lowest dose and monitor acid-base status and symptoms of salicylism.
What other medicines interact with Bismuth subsalicylate?
MediHelp also lists interactions of Bismuth subsalicylate with, for example, Warfarin, Acetylsalicylic acid, Amlodipine-benazepril. The full list is on the Bismuth subsalicylate page.
تکنگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.